Clin2
NCT06374875Possibly a fitRecruiting

Does metabolic surgery reduce liver scarring?

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Non-Alcoholic Fatty Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)Liver FibrosisObesity

Part of Digestive system, Hormones & metabolism clinical trials.

This study tests if weight loss surgery can improve liver fibrosis (scarring) in people with obesity and advanced liver disease. It may help those considering surgery to know if their liver health can get better.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
120 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • Your body mass index (BMI) is between 35 and 70.
  • You are a candidate for weight loss surgery (gastric bypass or sleeve gastrectomy).
  • Tests show you have advanced liver scarring (fibrosis).
  • Your weight has been stable (no more than 10% change) in the last 6 months.
  • You are willing to have two liver biopsies (one before and one 2 years after surgery).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07760909Not yet recruiting
Studying liver health in people having weight-loss surgery

This study looks at how fat build-up in the liver relates to metabolism in people who are scheduled for weight-loss (bariatric) surgery. By doing special blood tests and MRI scans, researchers hope to better understand liver health and improve care.

NCT06845345Enrolling by invitation· Phase 4
Can a special diet or pills help liver health?

This study compares two treatments for liver scarring in people with overweight or related health issues. One group follows a special diet with restricted eating times, while the other takes a combination of two medications (naltrexone and bupropion). It aims to see which approach better improves liver fibrosis.

Rotterdam
NCT03472157Recruiting
Bariatric surgery for severe NASH with advanced liver scarring

This study tests whether bariatric surgery (either sleeve gastrectomy or Roux-en-Y gastric bypass) improves severe nonalcoholic steatohepatitis (NASH) with advanced liver scarring in people who are obese. You may also need liver biopsies to confirm your liver disease before and after treatment.

Lille
NCT07188220Recruiting
Understanding patient views on fatty liver disease study

This study asks people with metabolic fatty liver disease and liver scarring about their experiences. It aims to learn what matters to you so doctors can improve care.

Barcelona
NCT07658755Recruiting
LiverSeek: Finding advanced liver scarring in MASLD

This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.

Madrid, Madrid
NCT05551559Enrolling by invitation
How bariatric surgery changes liver metabolism in fatty liver disease

This study looks at how bariatric (weight-loss) surgery affects how your liver processes nutrients in people with non-alcoholic fatty liver disease. It may help researchers understand what changes in the body after surgery and whether that could guide better future care.

Helsinki

Hear when a new Liver Fibrosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.